Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Autoimmune Disorders

Free Subscription Articles published in J Rheumatol Retrieve available abstracts of 226 articles: HTML format

Single Articles

June 2021
1. VILLIGER PM
   Giant Cell Arteritis: Real-life Experience.
   J Rheumatol. 2021 Jun 1. pii: jrheum.210334. doi: 10.3899/jrheum.210334.
   PubMed     Abstract available
   
   
   May 2021
2. HAZLEWOOD GS, Pardo J, Barnabe C, Schieir O, et al
   Canadian Rheumatology Association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases.
   J Rheumatol. 2021 May 15. pii: jrheum.210288. doi: 10.3899/jrheum.210288.
   PubMed     Abstract available
   
   
   
3. RAHMAN A
   Why Do Patients With Systemic Lupus Erythematosus Suffer Pain?
   J Rheumatol. 2021 May 1. pii: jrheum.210057. doi: 10.3899/jrheum.210057.
   PubMed     Abstract available
   
   
   April 2021
4. DIAZ T, Dominguez D, Jaeggi E, Knight A, et al
   Ethnicity and Neonatal Lupus Erythematosus Manifestations Risk in a Large Multi-Ethnic Cohort.
   J Rheumatol. 2021 Apr 1. pii: jrheum.201338. doi: 10.3899/jrheum.201338.
   PubMed     Abstract available
   
   
   
5. LANGLEBEN D, Berkson L, Chartrand S
   Selexipag Therapy for Raynaud Phenomenon-induced Severe Digital Ischemia in Intravenous Epoprostenol Responders With Connective Tissue Disease.
   J Rheumatol. 2021;48:616-617.
   PubMed    
   
   
   March 2021
6. RUSSELL AS
   The Variability of Antinuclear Antibody Testing.
   J Rheumatol. 2021 Mar 15. pii: jrheum.210039. doi: 10.3899/jrheum.210039.
   PubMed     Abstract available
   
   
   
7. MOHAMMAD AJ, Turkiewicz A, Stamatis P, Turesson C, et al
   Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis - A Population-Based Study.
   J Rheumatol. 2021 Mar 1. pii: jrheum.201131. doi: 10.3899/jrheum.201131.
   PubMed     Abstract available
   
   
   
8. ROSSIDES M
   Stroke is Different in Systemic Lupus Erythematosus: Implications for Survival and Functionality.
   J Rheumatol. 2021 Mar 1. pii: jrheum.201209. doi: 10.3899/jrheum.201209.
   PubMed     Abstract available
   
   
   February 2021
9. CLEMENT J, Duffau P, Constans J, Schaeverbeke T, et al
   Real-world risk of relapse of giant cell arteritis treated with tocilizumab: A retrospective analysis of 43 patients.
   J Rheumatol. 2021 Feb 15. pii: jrheum.200952. doi: 10.3899/jrheum.200952.
   PubMed     Abstract available
   
   
   
10. VYNCKIER J, Demeestere J, Lambert J
    Black-blood Magnetic Resonance Imaging in Giant Cell Arteritis.
    J Rheumatol. 2021;48:301-302.
    PubMed    
    
    
    January 2021
11. AGARWAL S
    Update on Sweet Syndrome in Eosinophilic Granulomatosis With Polyangiitis.
    J Rheumatol. 2021;48:151.
    PubMed    
    
    
    December 2020
12. ORLANDI M, Landini N, Bruni C, Colagrande S, et al
    Infection or autoimmunity? The clinical challenge of interstitial lung disease in systemic sclerosis during COVID 19 pandemic.
    J Rheumatol. 2020 Dec 1. pii: jrheum.200832. doi: 10.3899/jrheum.200832.
    PubMed     Abstract available
    
    
    
13. GERSTEIN M, Borgia RE, Dominguez D, Feldman BM, et al
    Predicting macrophage activation syndrome (MAS) in childhood-onsetsystemic lupus erythematosus (cSLE) patients at diagnosis.
    J Rheumatol. 2020 Dec 1. pii: jrheum.200292. doi: 10.3899/jrheum.200292.
    PubMed     Abstract available
    
    
    November 2020
14. GEORGE M, Venkatachalam S, Banerjee S, Baker JF, et al
    Concerns, healthcare use, and treatment interruptions in patients with common autoimmune rheumatic diseases during the COVID-19 pandemic.
    J Rheumatol. 2020 Nov 15. pii: jrheum.201017. doi: 10.3899/jrheum.201017.
    PubMed     Abstract available
    
    
    
15. ROSINA S, Varnier GC, Pistorio A, Pilkington C, et al
    Development and testing of reduced versions of the MMT-8 in juvenile dermatomyositis.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200543. doi: 10.3899/jrheum.200543.
    PubMed     Abstract available
    
    
    
16. BATU ED, Kaya Akca U, Pac Kisaarslan A, Sag E, et al
    The performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 classification criteria in pediatric systemic lupus erythematosus.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200871. doi: 10.3899/jrheum.200871.
    PubMed     Abstract available
    
    
    
17. LAMBERS WM, Westra J, Bootsma H, de Leeuw K, et al
    Hydroxychloroquine suppresses interferon-inducible genes and B-cell activating factor in patients with incomplete and new onset systemic lupus erythematosus.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200726. doi: 10.3899/jrheum.200726.
    PubMed     Abstract available
    
    
    
18. ZHANG B, Chi H, Su Y
    Near Tetraploidy in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2020;47:1725-1726.
    PubMed    
    
    
    
19. FAYE AS, Lee KE, Laszkowska M, Kim J, et al
    Risk of Adverse Outcomes in Hospitalized Patients with Autoimmune Disease and COVID-19: A Matched Cohort Study from New York City.
    J Rheumatol. 2020 Nov 1. pii: jrheum.200989. doi: 10.3899/jrheum.200989.
    PubMed     Abstract available
    
    
    
20. GAMWELL KL, Hommel KA
    Comprehensive Care in Pediatric Rheumatic Diseases: A Multifaceted Challenge.
    J Rheumatol. 2020;47:1603-1605.
    PubMed    
    
    
    October 2020
21. KIM JW, Jung JY, Kim HA, Yang JI, et al
    Lupus Low Disease Activity State achievement is important for reducing adverse outcomes in pregnant patients with systemic lupus erythematosus.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200802. doi: 10.3899/jrheum.200802.
    PubMed     Abstract available
    
    
    
22. DOMINGUEZ D, Kamphuis S, Beyene J, Wither J, et al
    Relationship between Genetic Risk and Age of Diagnosis of Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200002. doi: 10.3899/jrheum.200002.
    PubMed     Abstract available
    
    
    
23. MEHTA P, Sattui SE, van der Geest K, Brouwer E, et al
    Giant cell arteritis and COVID-19: similarities and discriminators, a systematic literature review.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200766. doi: 10.3899/jrheum.200766.
    PubMed     Abstract available
    
    
    September 2020
24. TROUNG L, Pourzand L, Volkmann ER
    Covid-19 in Patients with Connective Tissue Disease-Related Interstitial Lung Disease.
    J Rheumatol. 2020 Sep 15. pii: jrheum.201064. doi: 10.3899/jrheum.201064.
    PubMed     Abstract available
    
    
    
25. SALAMA AD, Caplin B
    Lupus Nephritis and Chronic Kidney Disease.
    J Rheumatol. 2020;47:1303-1304.
    PubMed    
    
    
    
26. TSELIOS K, Gladman DD, Taheri C, Su J, et al
    Factors Associated with Rapid Progression to End Stage Kidney Disease in Lupus Nephritis.
    J Rheumatol. 2020 Sep 1. pii: jrheum.200161. doi: 10.3899/jrheum.200161.
    PubMed     Abstract available
    
    
    
27. TSOI LK, Mok CC, Man BL, Fu YP, et al
    Imaging pattern and outcome of stroke in patients with systemic lupus erythematosus: a case-control study.
    J Rheumatol. 2020 Sep 1. pii: jrheum.200664. doi: 10.3899/jrheum.200664.
    PubMed     Abstract available
    
    
    August 2020
28. HIRAKI LT
    APOL1 Gene - Implications for Systemic Lupus Erythematosus.
    J Rheumatol. 2020;47:1155-1157.
    PubMed    
    
    
    July 2020
29. ALMAGHLOUTH I, Pullenayegum E, Gladman DD, Urowitz MB, et al
    Propensity Score Methods in Rare Disease. A Demonstration Using Observational Data in Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Jul 1. pii: jrheum.200254. doi: 10.3899/jrheum.200254.
    PubMed     Abstract available
    
    
    
30. MURIMI IB, Lin DH, Kan H, Tierce J, et al
    Health Care Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States.
    J Rheumatol. 2020 Jul 1. pii: jrheum.191187. doi: 10.3899/jrheum.191187.
    PubMed     Abstract available
    
    
    June 2020
31. QUEVEDO-ABELEDO JC, Sanchez-Perez H, Tejera-Segura B, de Armas-Rillo L, et al
    Higher Prevalence and Degree of Insulin Resistance in Patients with Rheumatoid Arthritis than in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Jun 15. pii: jrheum.200435. doi: 10.3899/jrheum.200435.
    PubMed     Abstract available
    
    
    
32. FAVALLI EG, Agape E, Caporali R
    Are patients with systemic lupus erythematosus at increased risk of severe COVID-19?
    J Rheumatol. 2020 Jun 1. pii: jrheum.200723. doi: 10.3899/jrheum.200723.
    PubMed     Abstract available
    
    
    
33. PESCHKEN CA
    Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
    J Rheumatol. 2020;47:787-790.
    PubMed    
    
    
    
34. SO H, Mak JWY, Tam LS
    No Systemic Lupus Erythematosus with COVID-19 in Hong Kong: The Effect of Masking?
    J Rheumatol. 2020 Jun 1. pii: jrheum.200605. doi: 10.3899/jrheum.200605.
    PubMed     Abstract available
    
    
    
35. STOUSTRUP P, Twilt M, Herlin T
    Systemic Treatment for Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2020;47:793-795.
    PubMed    
    
    
    May 2020
36. STAMATIS P, Turkiewicz A, Englund M, Jonsson G, et al
    Infections are associated with increased risk of giant cell arteritis - a population-based case-control study from Southern Sweden.
    J Rheumatol. 2020 May 15. pii: jrheum.200211. doi: 10.3899/jrheum.200211.
    PubMed     Abstract available
    
    
    
37. CHEN C, Yao B, Yan M, Su K, et al
    The plight of patients with lupus nephritis in Wuhan, China.
    J Rheumatol. 2020 May 8. pii: jrheum.200452. doi: 10.3899/jrheum.200452.
    PubMed     Abstract available
    
    
    
38. SILVA-DIAZ M, Freire Gonzalez M, Romero TH
    Pulmonary Alveolar Proteinosis in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2020;47:779-780.
    PubMed    
    
    
    
39. TURK MA, Hayworth JL, Nevskaya T, Pope JE, et al
    Ocular manifestations in rheumatoid arthritis, connective tissue disease and vasculitis: a systematic review and meta-analysis.
    J Rheumatol. 2020 May 1. pii: jrheum.190768. doi: 10.3899/jrheum.190768.
    PubMed     Abstract available
    
    
    
40. KWAK SG, Par SH, Kim JY
    Incidence and prevalence of juvenile systemic lupus erythematosus in Korea: data from the national health claims database 2017.
    J Rheumatol. 2020 May 1. pii: jrheum.191186. doi: 10.3899/jrheum.191186.
    PubMed     Abstract available
    
    
    April 2020
41. FAVALLI EG, Agape E, Caporali R
    Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis.
    J Rheumatol. 2020 Apr 25. pii: jrheum.200507. doi: 10.3899/jrheum.200507.
    PubMed     Abstract available
    
    
    
42. ERNSTE FC, Chong C, Crowson CS, Kermani TA, et al
    Functional Index-3: A Valid and Reliable Functional Outcome Assessment Measure in Dermatomyositis and Polymyositis Patients.
    J Rheumatol. 2020 Apr 15. pii: jrheum.191374. doi: 10.3899/jrheum.191374.
    PubMed     Abstract available
    
    
    
43. TSELIOS K, Gladman DD, Su J, Urowitz MB, et al
    Advanced Chronic Kidney Disease in Lupus Nephritis: Is Dialysis Inevitable?
    J Rheumatol. 2020 Apr 1. pii: jrheum.191064. doi: 10.3899/jrheum.191064.
    PubMed     Abstract available
    
    
    
44. TAKEUCHI T, Wakasugi N, Makino H
    Long-term safety and effectiveness of tacrolimus in lupus nephritis patients: 5- year interim post-marketing surveillance study in Japan (TRUST).
    J Rheumatol. 2020 Apr 1. pii: jrheum.191008. doi: 10.3899/jrheum.191008.
    PubMed     Abstract available
    
    
    
45. LIU K, Tomlinson G, Reed AM, Huber AM, et al
    Pilot study of the juvenile dermatomyositis consensus treatment plans: a CARRA Registry study.
    J Rheumatol. 2020 Apr 1. pii: jrheum.190494. doi: 10.3899/jrheum.190494.
    PubMed     Abstract available
    
    
    
46. UROWITZ MB, Gladman DD, Ibanez D, Su J, et al
    Impact of disease activity on organ damage progression in systemic lupus erythematosus: University of Toronto Lupus Clinic Cohort.
    J Rheumatol. 2020 Apr 1. pii: jrheum.190259. doi: 10.3899/jrheum.190259.
    PubMed     Abstract available
    
    
    March 2020
47. CLAIRMAN H, Dover S, Whitney K, Marcuz JA, et al
    Correlation of a Modified Disease Activity Score with the Validated Original Disease Activity Score in Patients with Juvenile Dermatomyositis.
    J Rheumatol. 2020 Mar 15. pii: jrheum.191255. doi: 10.3899/jrheum.191255.
    PubMed     Abstract available
    
    
    
48. NAIDES SJ, Genzen JR, Abel G, Bashleben C, et al
    Antinuclear Antibodies (ANA) Testing Method Variability: A Survey of Participants in the College of American Pathologists' (CAP) Proficiency Testing Program.
    J Rheumatol. 2020 Mar 15. pii: jrheum.190933. doi: 10.3899/jrheum.190933.
    PubMed     Abstract available
    
    
    
49. HOGE C, Bowling CB, Lim SS, Drenkard C, et al
    Association of Poverty Income Ratio with Physical Functioning in a Cohort of Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Mar 1. pii: jrheum.190991. doi: 10.3899/jrheum.190991.
    PubMed     Abstract available
    
    
    February 2020
50. MOISEEV S, Zykova A, Bulanov N, Gitel E, et al
    Is There a Role for LAMP-2 Autoantibodies in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis?
    J Rheumatol. 2020 Feb 15. pii: jrheum.191082. doi: 10.3899/jrheum.191082.
    PubMed     Abstract available
    
    
    
51. WARD JM, Hess JN, Davis LS
    Targetoid-like Lesions in the Setting of Systemic Lupus Erythematosus: A Case of Rowell Syndrome.
    J Rheumatol. 2020;47:298-299.
    PubMed    
    
    
    
52. CHANG JC, Knight AM, Lawson EF
    Patterns of Health Care Utilization and Medication Adherence Among Youth with Systemic Lupus Erythematosus During Transfer from Pediatric to Adult Care.
    J Rheumatol. 2020 Feb 1. pii: jrheum.191029. doi: 10.3899/jrheum.191029.
    PubMed     Abstract available
    
    
    January 2020
53. CANNON L, Dvergsten J, Stingl C
    Juvenile Dermatomyositis and Development of Malignancy: 2 Case Reports and a Literature Review.
    J Rheumatol. 2020 Jan 15. pii: jrheum.190929. doi: 10.3899/jrheum.190929.
    PubMed     Abstract available
    
    
    December 2019
54. MOORE S, Juo HH, Nielsen CT, Tyden H, et al
    Neutrophil extracellular traps identify patients at risk of increased disease activity and cardiovascular comorbidity in systemic lupus erythematosus.
    J Rheumatol. 2019 Dec 15. pii: jrheum.190875. doi: 10.3899/jrheum.190875.
    PubMed     Abstract available
    
    
    
55. BEN-SHABAT N, Tiosano S, Shovman O, Comaneshter D, et al
    Mortality among patients with giant-cell arteritis: A large-scale population-based cohort study.
    J Rheumatol. 2019 Dec 15. pii: jrheum.190927. doi: 10.3899/jrheum.190927.
    PubMed     Abstract available
    
    
    
56. CHUA MHY, Ng IAT, Cheung MWL, Mak A, et al
    Association Between Cigarette Smoking and Systemic Lupus Erythematosus - an Updated Multivariate Bayesian Metaanalysis.
    J Rheumatol. 2019 Dec 1. pii: jrheum.190733. doi: 10.3899/jrheum.190733.
    PubMed     Abstract available
    
    
    
57. DAHAL LN, Barker RN, Ward FJ
    The Soluble Isoform of CTLA-4 Correlates with Interferon-alpha Activity in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Dec 1. pii: jrheum.190678. doi: 10.3899/jrheum.190678.
    PubMed     Abstract available
    
    
    November 2019
58. VAJGEL G, Lima SC, Santana DJS, Oliveira CBL, et al
    A single APOL1 nephropathy variant increases risk of advanced lupus nephritis in Brazilians.
    J Rheumatol. 2019 Nov 15. pii: jrheum.190684. doi: 10.3899/jrheum.190684.
    PubMed     Abstract available
    
    
    
59. CHEN SK, Barbhaiya M, Solomon DH, Guan H, et al
    Atrial Fibrillation/Flutter Hospitalizations among U.S. Medicaid Recipients with and without Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Nov 1. pii: jrheum.190502. doi: 10.3899/jrheum.190502.
    PubMed     Abstract available
    
    
    
60. MORONI L, Restovic G, Cervera R, Espinosa G, et al
    Economic Impact Analysis of the Use of Anti-DFS70 Antibody Test In Patients with Undifferentiated Systemic Autoimmune Disease Symptoms.
    J Rheumatol. 2019 Nov 1. pii: jrheum.190533. doi: 10.3899/jrheum.190533.
    PubMed     Abstract available
    
    
    
61. 
    More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:1548.
    PubMed    
    
    
    October 2019
62. COUTURE P, Bachmeyer C, Monfort JB
    Koebner Phenomenon in Dermatomyositis after Subcutaneous Methotrexate Injections.
    J Rheumatol. 2019;46:1350.
    PubMed    
    
    
    
63. MORAND EF, Golder V
    Treat-to-target Endpoint Definitions in Systemic Lupus Erythematosus: More Is Less?
    J Rheumatol. 2019;46:1256-1258.
    PubMed    
    
    
    September 2019
64. RUACHO G, Kvarnstrom M, Zickert A, Oke V, et al
    Sjogren's syndrome in Systemic Lupus Erythematosus - a subset characterized by a systemic inflammatory state.
    J Rheumatol. 2019 Sep 15. pii: jrheum.190250. doi: 10.3899/jrheum.190250.
    PubMed     Abstract available
    
    
    
65. SMITH V, Distler O, Cutolo M
    Might Nailfold Capillaroscopy Be a "Proxy" for Lung Involvement in Connective Tissue Diseases?
    J Rheumatol. 2019;46:1061-1063.
    PubMed    
    
    
    
66. MUKWIKWI ER, Pineau CA, Vinet E, Clarke AE, et al
    Retinal Complications in Systemic Lupus Erythematosus Patients Treated with Antimalarial Drugs.
    J Rheumatol. 2019 Sep 1. pii: jrheum.181102. doi: 10.3899/jrheum.181102.
    PubMed     Abstract available
    
    
    
67. SMITHERMAN EA, Huang B, Furnier A, Taylor J, et al
    Quality of care in childhood-onset systemic lupus erythematosus: Report of an intervention to improve cardiovascular and bone health screening.
    J Rheumatol. 2019 Sep 1. pii: jrheum.190295. doi: 10.3899/jrheum.190295.
    PubMed     Abstract available
    
    
    August 2019
68. KISHI T, Chipman J, Evereklian M, Nghiem K, et al
    Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis.
    J Rheumatol. 2019 Aug 1. pii: jrheum.181275. doi: 10.3899/jrheum.181275.
    PubMed     Abstract available
    
    
    July 2019
69. BREKKE LK, Fevang BS, Diamantopoulos AP, Assmus J, et al
    Risk of cancer in 767 patients with giant cell arteritis in western Norway: a retrospective cohort with matched controls.
    J Rheumatol. 2019 Jul 15. pii: jrheum.190147. doi: 10.3899/jrheum.190147.
    PubMed     Abstract available
    
    
    
70. DE LUCA G, Campochiaro C, Dagna L
    Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: The Role of Endomyocardial Biopsy.
    J Rheumatol. 2019 Jul 1. pii: jrheum.190078. doi: 10.3899/jrheum.190078.
    PubMed     Abstract available
    
    
    
71. LI C, Zhao J, Zhao Y
    Hepatic Infarction Caused by Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:755-756.
    PubMed    
    
    
    June 2019
72. STOJAN G, Magder LS, Petri M
    Blood Pressure Variability and Age-related Blood Pressure Patterns in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Jun 15. pii: jrheum.181131. doi: 10.3899/jrheum.181131.
    PubMed     Abstract available
    
    
    
73. WONG PC, Lee G, Sedie AD, Hanova P, et al
    Musculoskeletal Ultrasound in Systemic Lupus Erythematosus: Systematic Literature Review by the Lupus Task Force of the OMERACT Ultrasound Working Group.
    J Rheumatol. 2019 Jun 15. pii: jrheum.181087. doi: 10.3899/jrheum.181087.
    PubMed     Abstract available
    
    
    
74. LI YC, Chang DM, Lu CC
    Montreal Cognitive Assessment and Magnetic Resonance Imaging Identify Cognitive Impairment in Young Patients with Neuropsychiatric Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:653.
    PubMed    
    
    
    
75. STAMATIS P, Turesson C, Willim M, Nilsson JA, et al
    Malignancies In Giant Cell Arteritis: A Population-Based Cohort Study.
    J Rheumatol. 2019 Jun 1. pii: jrheum.190236. doi: 10.3899/jrheum.190236.
    PubMed     Abstract available
    
    
    May 2019
76. FELDMAN CH, Malspeis S, Leatherwood C, Kubzansky L, et al
    Association of Childhood Abuse with Incident Systemic Lupus Erythematosus in Adulthood in a Longitudinal Cohort of Women.
    J Rheumatol. 2019 May 15. pii: jrheum.190009. doi: 10.3899/jrheum.190009.
    PubMed     Abstract available
    
    
    
77. FUJISAWA T, Hozumi H, Yasui H, Suzuki Y, et al
    Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    J Rheumatol. 2019 May 15. pii: jrheum.180825. doi: 10.3899/jrheum.180825.
    PubMed     Abstract available
    
    
    
78. BRUSCHI M, Bonanni A, Petretto A, Vaglio A, et al
    Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis.
    J Rheumatol. 2019 May 15. pii: jrheum.181232. doi: 10.3899/jrheum.181232.
    PubMed     Abstract available
    
    
    
79. ORMSETH MJ, Solus JF, Sheng Q, Ye F, et al
    Development and Validation of a microRNA Panel to Differentiate between Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus and Controls.
    J Rheumatol. 2019 May 15. pii: jrheum.181029. doi: 10.3899/jrheum.181029.
    PubMed     Abstract available
    
    
    
80. BROUWER E, VAN DER Geest KSM, Sandovici M
    Methotrexate in Giant Cell Arteritis Deserves a Second Chance - A High-dose Methotrexate Trial Is Needed.
    J Rheumatol. 2019;46:453-454.
    PubMed    
    
    
    April 2019
81. LEGGE A, Kirkland S, Rockwood K, Andreou P, et al
    Construction of a frailty index as a novel health measure in systemic lupus erythematosus.
    J Rheumatol. 2019 Apr 15. pii: jrheum.181338. doi: 10.3899/jrheum.181338.
    PubMed     Abstract available
    
    
    
82. RUA-FIGUEROA I, Lopez-Longo F, Del Campo V, Galindo-Izquierdo M, et al
    Bacteremia in systemic lupus erythematosus patients from RELESSER: risk factors, clinical and microbiological characteristics and outcomes.
    J Rheumatol. 2019 Apr 15. pii: jrheum.180882. doi: 10.3899/jrheum.180882.
    PubMed     Abstract available
    
    
    
83. MILLS BS, Dao KH, Tecson KM, Fishman E, et al
    Perceptions of Pregnancy and Lactation from the Pregnancy and Lactation Autoimmune Network (PLAN) Registry.
    J Rheumatol. 2019 Apr 1. pii: jrheum.181067. doi: 10.3899/jrheum.181067.
    PubMed     Abstract available
    
    
    
84. BESSE MC, Collercandy N, Diot E
    Gynecologic Vasculitis: Positron Emission Tomography-Computed Tomography Contribution in a Rare Localization of Giant Cell Arteritis.
    J Rheumatol. 2019;46:439.
    PubMed    
    
    
    
85. BUTENDIECK RR JR, Abril A, Cortese C
    Dr. Butendieck, et al, reply.
    J Rheumatol. 2019;46:439-440.
    PubMed    
    
    
    
86. SANDHU VK, Weisman MH
    Hydroxychloroquine - How Much Is Too Much?
    J Rheumatol. 2019;46:340-342.
    PubMed    
    
    
    March 2019
87. WITCZAK BN, Hetlevik SO, Sanner H, Barth Z, et al
    Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180526. doi: 10.3899/jrheum.180526.
    PubMed     Abstract available
    
    
    
88. LI C, Yap DYH, Chan G, Wen YB, et al
    Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy showing Thrombotic Microangiopathy.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180773. doi: 10.3899/jrheum.180773.
    PubMed     Abstract available
    
    
    
89. DUMONT A, Parienti JJ, Delmas C, Boutemy J, et al
    Factors Associated with Relapse and Dependence to Glucocorticoids in Giant-Cell Arteritis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.181127. doi: 10.3899/jrheum.181127.
    PubMed     Abstract available
    
    
    
90. TERRE A, Talbot A, Louvrier C, Picque JB, et al
    Monoclonal gammopathy, arthralgias, and recurrent fever syndrome: a new autoinflammatory syndrome?
    J Rheumatol. 2019 Mar 15. pii: jrheum.181204. doi: 10.3899/jrheum.181204.
    PubMed     Abstract available
    
    
    
91. BANERJEE S, Quinn KA, Gribbons KB, Rosenblum JS, et al
    Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-Vessel Vasculitis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.181222. doi: 10.3899/jrheum.181222.
    PubMed     Abstract available
    
    
    
92. TAMAI H, Nishina N, Takeuchi T
    Pulmonary Vein Vasculitis Presenting as Multiple Pulmonary Nodules in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:323-324.
    PubMed    
    
    
    
93. SHA SJ, Hou JH, Xie GT, Sun W, et al
    Improvement of outcomes in patients with lupus nephritis: management evolution in Chinese patients from 1994 to 2010.
    J Rheumatol. 2019 Mar 1. pii: jrheum.180145. doi: 10.3899/jrheum.180145.
    PubMed     Abstract available
    
    
    
94. UGARTE-GIL MF, Wojdyla D, Pons-Estel GJ, Quintana R, et al
    Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a multi-ethnic, multinational Latin-American Lupus Cohort.
    J Rheumatol. 2019 Mar 1. pii: jrheum.180433. doi: 10.3899/jrheum.180433.
    PubMed     Abstract available
    
    
    
95. SOLOMON IH, Docken WP, Padera RF
    Giant cell arteritis is not associated with varicella zoster virus in temporal artery biopsies or ascending aortic resections.
    J Rheumatol. 2019 Mar 1. pii: jrheum.180912. doi: 10.3899/jrheum.180912.
    PubMed     Abstract available
    
    
    February 2019
96. TAO JJ, Hiraki LT, Levy DM, Silverman ED, et al
    Comparison of Sensitivities of American College of Rheumatology and Systemic Lupus International Collaborating Clinics Classification Criteria in Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 15. pii: jrheum.180337. doi: 10.3899/jrheum.180337.
    PubMed     Abstract available
    
    
    
97. OTOBO TM, Conaghan PG, Maksymowych WP, van der Heijde D, et al
    Preliminary Definitions for Sacroiliac Joint Pathologies in the OMERACT Juvenile Idiopathic Arthritis MRI Score (OMERACT JAMRIS-SIJ).
    J Rheumatol. 2019 Feb 15. pii: jrheum.181115. doi: 10.3899/jrheum.181115.
    PubMed     Abstract available
    
    
    
98. BARBACKI A, Petri M, Avina-Zubieta A, Alarcon GS, et al
    Fatigue Measurements in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180831. doi: 10.3899/jrheum.180831.
    PubMed     Abstract available
    
    
    
99. UROWITZ MB, Su J, Gladman DD
    Atherosclerotic Vascular Events in Systemic Lupus Erythematosus - an Evolving Story.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180986. doi: 10.3899/jrheum.180986.
    PubMed     Abstract available
    
    
    
100. LIU LH, Fevrier HB, Goldfien R, Hemmerling A, et al
     Understanding Non-Adherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus.
     J Rheumatol. 2019 Feb 1. pii: jrheum.180946. doi: 10.3899/jrheum.180946.
     PubMed     Abstract available
     
     
     
101. BEUKELMAN T, Nigrovic PA
     Juvenile Idiopathic Arthritis: An Idea Whose Time Has Gone?
     J Rheumatol. 2019;46:124-126.
     PubMed    
     
     
     January 2019
102. MERAYO-CHALICO J, Barrera-Vargas A, Morales-Padilla S, Reyna-De la Garza R, et al
     Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American Landscape.
     J Rheumatol. 2019 Jan 15. pii: jrheum.180292. doi: 10.3899/jrheum.180292.
     PubMed     Abstract available
     
     
     
103. WIRESTAM L, Enocsson H, Skogh T, Padyukov L, et al
     Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
     J Rheumatol. 2019 Jan 15. pii: jrheum.180713. doi: 10.3899/jrheum.180713.
     PubMed     Abstract available
     
     
     
104. QUEVEDO-ABELEDO JC, Rua-Figueroa I, Sanchez-Perez H, Tejera-Segura B, et al
     Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus.
     J Rheumatol. 2019 Jan 15. pii: jrheum.180881. doi: 10.3899/jrheum.180881.
     PubMed     Abstract available
     
     
     
105. KOSTER MJ, Yeruva K, Crowson CS, Muratore F, et al
     Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.
     J Rheumatol. 2019 Jan 15. pii: jrheum.180429. doi: 10.3899/jrheum.180429.
     PubMed     Abstract available
     
     
     
106. BREKKE LK, Fevang BT, Myklebust G
     Increased Incidence of Giant Cell Arteritis in Urban Areas?
     J Rheumatol. 2019 Jan 15. pii: jrheum.180714. doi: 10.3899/jrheum.180714.
     PubMed     Abstract available
     
     
     
107. HOZUMI H, Fujisawa T, Nakashima R, Yasui H, et al
     Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
     J Rheumatol. 2019 Jan 15. pii: jrheum.180778. doi: 10.3899/jrheum.180778.
     PubMed     Abstract available
     
     
     
108. ZHANG S, Zhang F, Li Y
     Should aPS/PT Be Incorporated into the Routine Serological Tests in the Diagnosis of Antiphospholipid Syndrome?
     J Rheumatol. 2019;46:114-116.
     PubMed    
     
     
     
109. ZOHOURY N
     N. Zohoury replies.
     J Rheumatol. 2019;46:116-117.
     PubMed    
     
     
     
110. ZHAO Y, Rascoff NE, Iyer RS, Thapa M, et al
     Dr. Zhao, et al, reply.
     J Rheumatol. 2019;46:113-114.
     PubMed    
     
     
     
111. ROTH J
     Predictive Value of Musculoskeletal Ultrasound for Flares in Juvenile Idiopathic Arthritis.
     J Rheumatol. 2019;46:113.
     PubMed    
     
     
     December 2018
112. JOHNSON SR, Khanna D, Daikh D, Cervera R, et al
     Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.
     J Rheumatol. 2018 Dec 15. pii: jrheum.180478. doi: 10.3899/jrheum.180478.
     PubMed     Abstract available
     
     
     
113. VAN ROON AM, Huisman CC, van Roon AM, Zhang D, et al
     Abnormal Nailfold Capillaroscopy Is Common in Patients with Connective Tissue Disease and Associated with Abnormal Pulmonary Function Tests.
     J Rheumatol. 2018 Dec 15. pii: jrheum.180615. doi: 10.3899/jrheum.180615.
     PubMed     Abstract available
     
     
     
114. HAGEN M, Englbrecht M, Haschka J, Reiser M, et al
     Cost-effective Tapering Algorithm in Rheumatoid Arthritis Patients: Combination of Multibiomarker Disease Activity Score and Autoantibody Status.
     J Rheumatol. 2018 Dec 1. pii: jrheum.180028. doi: 10.3899/jrheum.180028.
     PubMed     Abstract available
     
     
     
115. SUN YS, Huang DF, Lin FC, Hsu CK, et al
     Cytomegaloviral or Pneumocystis Jiroveci Pneumonia Increases Mortality in Systemic Lupus Erythematosus Patients with Pulmonary Hemorrhage: Evidence from Bronchoalveolar Lavage Fluid.
     J Rheumatol. 2018 Dec 1. pii: jrheum.180104. doi: 10.3899/jrheum.180104.
     PubMed     Abstract available
     
     
     
116. 
     The Effect of Vitamin D Supplementation on Inflammatory and Hemostatic Markers and Disease Activity in Patients with Systemic Lupus Erythematosus: A Randomized Placebo-controlled Trial.
     J Rheumatol. 2018;45:1713.
     PubMed    
     
     
     
117. GREMESE E, DE Lorenzis E, Ferraccioli GF
     Statins and Mortality in Connective Tissue Diseases: Should We Resume the Cardio-rheumatology Spirit in Our Clinics?
     J Rheumatol. 2018;45:1617-1619.
     PubMed    
     
     
     November 2018
118. MAESHIMA K, Ishii K, Shibata H
     An Adult Fatal Case with a STAT1 Gain-of-function Mutation Associated with Multiple Autoimmune Diseases.
     J Rheumatol. 2018 Nov 15. pii: jrheum.180210. doi: 10.3899/jrheum.180210.
     PubMed     Abstract available
     
     
     
119. PRADSGAARD DO, Horlyck A, Spannow AH, Heuck C, et al
     A Comparison of Radiographic Joint Space Width Measurements Versus Ultrasonographic Assessment of Cartilage Thickness in Children with Juvenile Idiopathic Arthritis.
     J Rheumatol. 2018 Nov 15. pii: jrheum.170571. doi: 10.3899/jrheum.170571.
     PubMed     Abstract available
     
     
     
120. UGOLINI R, Muratore F, Salvarani C
     Cardiac and Pulmonary Artery Involvement Detected by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Large-vessel Giant Cell Arteritis.
     J Rheumatol. 2018;45:1603-1604.
     PubMed    
     
     
     October 2018
121. TSELIOS K, Deeb M, Gladman DD, Harvey P, et al
     Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?
     J Rheumatol. 2018 Oct 15. pii: jrheum.180124. doi: 10.3899/jrheum.180124.
     PubMed     Abstract available
     
     
     
122. YAMADA S, Nagafuchi Y, Fujio K
     Retro-odontoid Pseudotumor Associated with Sjogren Syndrome and Systemic Lupus Erythematosus Serology.
     J Rheumatol. 2018;45:1424-1425.
     PubMed    
     
     
     
123. YAP DYH, Tang C, Chan GCW, Kwan LPY, et al
     Longterm Data on Sirolimus Treatment in Patients with Lupus Nephritis.
     J Rheumatol. 2018 Oct 1. pii: jrheum.180507. doi: 10.3899/jrheum.180507.
     PubMed     Abstract available
     
     
     September 2018
124. PESCHKEN CA, Wang Y, Abrahamowicz M, Pope J, et al
     Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Sep 15. pii: jrheum.171454. doi: 10.3899/jrheum.171454.
     PubMed     Abstract available
     
     
     
125. VAN DELFT MAM, van Beest S, Kloppenburg M, Trouw LA, et al
     Presence of Autoantibodies in Erosive Hand Osteoarthritis and Association with Clinical Presentation.
     J Rheumatol. 2018 Sep 15. pii: jrheum.180256. doi: 10.3899/jrheum.180256.
     PubMed     Abstract available
     
     
     
126. FAGUER S, Belliere J, Ribes D
     Complement C5-blocking Agent in Refractory Dermatomyositis.
     J Rheumatol. 2018 Sep 15. pii: jrheum.180060. doi: 10.3899/jrheum.180060.
     PubMed     Abstract available
     
     
     
127. JORGE AM, Lu N, Keller SF, Rai SK, et al
     The Effect of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases.
     J Rheumatol. 2018 Sep 1. pii: jrheum.171389. doi: 10.3899/jrheum.171389.
     PubMed     Abstract available
     
     
     
128. GARG S, Tsagaris K, Cozmuta R, Lipson A, et al
     Improving the Combination Pneumococcal Vaccination Rate in Systemic Lupus Erythematosus Patients at an Adult Rheumatology Practice.
     J Rheumatol. 2018 Sep 1. pii: jrheum.171377. doi: 10.3899/jrheum.171377.
     PubMed     Abstract available
     
     
     
129. KEELING SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, et al
     Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Sep 1. pii: jrheum.171459. doi: 10.3899/jrheum.171459.
     PubMed     Abstract available
     
     
     
130. MITANDER A, Fei Y, Trysberg E, Mohammad M, et al
     Complement Consumption in Systemic Lupus Erythematosus Leads to Decreased Opsonophagocytosis In Vitro.
     J Rheumatol. 2018 Sep 1. pii: jrheum.171325. doi: 10.3899/jrheum.171325.
     PubMed     Abstract available
     
     
     August 2018
131. KEELING SO, Vandermeer B, Medina J, Chatterley T, et al
     Measuring Disease Activity and Damage with Validated Metrics: A Systematic Review on Mortality and Damage in Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Aug 15. pii: jrheum.171310. doi: 10.3899/jrheum.171310.
     PubMed     Abstract available
     
     
     
132. VAN DIJKHUIZEN EHP, Vanoni F, Magnano GM, Magnaguagno F, et al
     Effect of the Inclusion of the Metacarpophalangeal Joints on the Wrist Magnetic Resonance Imaging Scoring System in Juvenile Idiopathic Arthritis.
     J Rheumatol. 2018 Aug 15. pii: jrheum.171246. doi: 10.3899/jrheum.171246.
     PubMed     Abstract available
     
     
     
133. HETLEVIK SO, Flato B, Aalokken TM, Lund MB, et al
     Pulmonary Manifestations and Progression of Lung Disease in Juvenile-onset Mixed Connective Tissue Disease.
     J Rheumatol. 2018 Aug 1. pii: jrheum.180019. doi: 10.3899/jrheum.180019.
     PubMed     Abstract available
     
     
     
134. LIPHAUS BL, Sallum AEM, Aikawa NE, Kiss MHB, et al
     Increased Soluble Cytoplasmic Bcl-2 Protein Serum Levels and Expression and Decreased Fas Expression in Lymphocytes and Monocytes in Juvenile Dermatomyositis.
     J Rheumatol. 2018 Aug 1. pii: jrheum.171248. doi: 10.3899/jrheum.171248.
     PubMed     Abstract available
     
     
     
135. TSELIOS K, Gladman DD, Harvey P, Akhtari S, et al
     Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?
     J Rheumatol. 2018 Aug 1. pii: jrheum.171436. doi: 10.3899/jrheum.171436.
     PubMed     Abstract available
     
     
     
136. KEELING SO, Bissonauth A, Bernatsky S, Vandermeer B, et al
     Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada.
     J Rheumatol. 2018 Aug 1. pii: jrheum.171307. doi: 10.3899/jrheum.171307.
     PubMed     Abstract available
     
     
     
137. BUTENDIECK RR JR, Abril A, Cortese C
     Unusual Presentation of Giant Cell Arteritis in 2 Patients: Uterine Involvement.
     J Rheumatol. 2018;45:1201-1202.
     PubMed    
     
     
     July 2018
138. GARNIER C, Ribes D, Chauveau D, Huart A, et al
     Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.
     J Rheumatol. 2018 Jul 15. pii: jrheum.180310. doi: 10.3899/jrheum.180310.
     PubMed     Abstract available
     
     
     
139. YUE C, Su J, Gao R, Wen Y, et al
     Characteristics and Outcomes of Patients with Systemic Lupus Erythematosus-associated Thrombotic Microangiopathy, and Their Acquired ADAMTS13 Inhibitor Profiles.
     J Rheumatol. 2018 Jul 15. pii: jrheum.170811. doi: 10.3899/jrheum.170811.
     PubMed     Abstract available
     
     
     
140. ZAMPELI E, Kalogirou EM, Piperi E, Mavragani CP, et al
     Tongue Atrophy in Sjogren Syndrome Patients with Mucosa-associated Lymphoid Tissue Lymphoma: Autoimmune Epithelitis beyond the Epithelial Cells of Salivary Glands?
     J Rheumatol. 2018 Jul 15. pii: jrheum.180101. doi: 10.3899/jrheum.180101.
     PubMed     Abstract available
     
     
     
141. CANTI V, Del Rosso S, Tonello M, Luciano R, et al
     Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.
     J Rheumatol. 2018 Jul 15. pii: jrheum.170751. doi: 10.3899/jrheum.170751.
     PubMed     Abstract available
     
     
     
142. BATU ED, Kosukcu C, Taskiran E, Sahin S, et al
     Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Jul 15. pii: jrheum.171358. doi: 10.3899/jrheum.171358.
     PubMed     Abstract available
     
     
     
143. MCDONALD EG, Bissonette L, Ensworth S, Dayan N, et al
     Monitoring of Systemic Lupus Erythematosus Pregnancies: A Systematic Literature Review.
     J Rheumatol. 2018 Jul 15. pii: jrheum.171023. doi: 10.3899/jrheum.171023.
     PubMed     Abstract available
     
     
     
144. EUDY AM, Siega-Riz AM, Engel SM, Franceschini N, et al
     Preconceptional Cardiovascular Health and Pregnancy Outcomes in Women with Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Jul 15. pii: jrheum.171066. doi: 10.3899/jrheum.171066.
     PubMed     Abstract available
     
     
     
145. ALHARBI S, Ahmad Z, Bookman AA, Touma Z, et al
     Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
     J Rheumatol. 2018 Jul 15. pii: jrheum.170953. doi: 10.3899/jrheum.170953.
     PubMed     Abstract available
     
     
     
146. HUSSEIN S, Suitner M, Beland-Bonenfant S, Baril-Dionne A, et al
     Monitoring of Osteonecrosis in Systemic Lupus Erythematosus Patients: A Systematic Review and Metaanalysis.
     J Rheumatol. 2018 Jul 1. pii: jrheum.170837. doi: 10.3899/jrheum.170837.
     PubMed     Abstract available
     
     
     
147. SCHAFER VS, Chrysidis S, Dejaco C, Duftner C, et al
     Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability Exercises.
     J Rheumatol. 2018 Jul 1. pii: jrheum.171428. doi: 10.3899/jrheum.171428.
     PubMed     Abstract available
     
     
     
148. BAICUS C
     At What Age Was Systemic Lupus Erythematosus Diagnosed in This Cohort?
     J Rheumatol. 2018;45:1070.
     PubMed    
     
     
     June 2018
149. XIE L, Xu J
     Role of MiR-98 and Its Underlying Mechanisms in Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Jun 15. pii: jrheum.171290. doi: 10.3899/jrheum.171290.
     PubMed     Abstract available
     
     
     
150. TROLDBORG A, Thiel S, Trendelenburg M, Friebus-Kardash J, et al
     The Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Jun 15. pii: jrheum.171033. doi: 10.3899/jrheum.171033.
     PubMed     Abstract available
     
     
     
151. ZAMPELI E, Skopouli FN, Moutsopoulos HM
     Polyserositis in a Patient with Active Systemic Lupus Erythematosus: A Case of Pseudo-pseudo Meigs Syndrome.
     J Rheumatol. 2018;45:877-878.
     PubMed    
     
     
     
152. FONGAUFIER C, Guffroy A, Lutz JC
     Tongue and Scalp Necrosis: Simultaneous Initial Complications Revealing Giant Cell Arteritis.
     J Rheumatol. 2018;45:873-874.
     PubMed    
     
     
     
153. LABRADOR-HORRILLO M, Selva-O'Callaghan A
     Cancer-associated Dermatomyositis: Does the PD-1 Checkpoint Pathway Play a Role?
     J Rheumatol. 2018;45:731-732.
     PubMed    
     
     
     
154. TSELIOS K, Gladman DD, Touma Z, Su J, et al
     Monophasic Disease Course in Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Jun 1. pii: jrheum.171319. doi: 10.3899/jrheum.171319.
     PubMed     Abstract available
     
     
     
155. GUDERUD K, Maehlen MT, Nordang GBN, Viken MK, et al
     Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies, PADI4 Polymorphisms, and Clinical Characteristics in Rheumatoid Arthritis.
     J Rheumatol. 2018 Jun 1. pii: jrheum.170769. doi: 10.3899/jrheum.170769.
     PubMed     Abstract available
     
     
     April 2018
156. RAISSI TC, Hewson C, Pope JE
     Repeat Testing of Antibodies and Complements in Systemic Lupus Erythematosus: When Is It Enough?
     J Rheumatol. 2018 Apr 15. pii: jrheum.161365. doi: 10.3899/jrheum.161365.
     PubMed     Abstract available
     
     
     
157. NANGIT A, Lin C, Ishimori ML, Spiegel BMR, et al
     Causes and Predictors of Early Hospital Readmission in Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Apr 15. pii: jrheum.170176. doi: 10.3899/jrheum.170176.
     PubMed     Abstract available
     
     
     
158. TANHA N, Hansen RB, Nielsen CT, Faurschou M, et al
     Clinical and Serological Associations with the Development of Incident Proteinuria in Danish Patients with Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Apr 15. pii: jrheum.170933. doi: 10.3899/jrheum.170933.
     PubMed     Abstract available
     
     
     
159. KAWASUMI H, Katsumata Y, Nishino A, Hirahara S, et al
     Association of Serum Soluble CD163 with Polymyositis and Dermatomyositis, Especially in Anti-MDA5 Antibody-positive Cases.
     J Rheumatol. 2018 Apr 15. pii: jrheum.170997. doi: 10.3899/jrheum.170997.
     PubMed     Abstract available
     
     
     
160. VEGA-MORALES D, Hernandez-Galarza IJ, Galarza-Delgado DA
     Causes of Hospital Mortality in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus in a University Hospital: 1998-2015 Analysis.
     J Rheumatol. 2018;45:583-584.
     PubMed    
     
     
     
161. ZHAO Y, Rascoff NE, Iyer RS, Thapa M, et al
     Flares of Disease in Children with Clinically Inactive Juvenile Idiopathic Arthritis Were Not Correlated with Ultrasound Findings.
     J Rheumatol. 2018 Apr 1. pii: jrheum.170681. doi: 10.3899/jrheum.170681.
     PubMed     Abstract available
     
     
     March 2018
162. ROMERO-DIAZ J, Acosta-Hernandez RI, Criales-Vera S, Kimura-Hayama E, et al
     Asymptomatic Coronary Artery Calcifications in Men with Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Mar 15. pii: jrheum.170330. doi: 10.3899/jrheum.170330.
     PubMed     Abstract available
     
     
     
163. YANG J, Yang X, Yang J, Li M, et al
     Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Mar 15. pii: jrheum.170737. doi: 10.3899/jrheum.170737.
     PubMed     Abstract available
     
     
     
164. LIOZON E, de Boysson H, Dalmay F, Gondran G, et al
     Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
     J Rheumatol. 2018 Mar 15. pii: jrheum.170455. doi: 10.3899/jrheum.170455.
     PubMed     Abstract available
     
     
     
165. FRITZLER MJ, Choi MY, Mahler M
     The Antinuclear Antibody Test in the Diagnosis of Antisynthetase Syndrome and Other Autoimmune Myopathies.
     J Rheumatol. 2018;45:444-445.
     PubMed    
     
     
     
166. BHANSING KJ, VAN Rosmalen MH, VAN Engelen BG, VAN Riel PL, et al
     Ultrasound: A Potential Tool for Detecting of Fasciitis in Dermatomyositis and Polymyositis.
     J Rheumatol. 2018;45:441-442.
     PubMed    
     
     
     
167. TIDWELL WJ, Callen JP
     Koebner Phenomenon in Juvenile Dermatomyositis.
     J Rheumatol. 2018;45:437.
     PubMed    
     
     
     
168. DAVIDSON JE, Fu Q, Ji B, Rao S, et al
     Renal Remission Status and Longterm Renal Survival in Patients with Lupus Nephritis: A Retrospective Cohort Analysis.
     J Rheumatol. 2018 Mar 1. pii: jrheum.161554. doi: 10.3899/jrheum.161554.
     PubMed     Abstract available
     
     
     February 2018
169. YUE C, Li G, Wen Y, Li X, et al
     Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
     J Rheumatol. 2018 Feb 15. pii: jrheum.170561. doi: 10.3899/jrheum.170561.
     PubMed     Abstract available
     
     
     
170. CAI F, Han F, Wang H, Han H, et al
     The Crescentic Implication of Renal Outcomes in Proliferative Lupus Nephritis.
     J Rheumatol. 2018 Feb 15. pii: jrheum.170553. doi: 10.3899/jrheum.170553.
     PubMed     Abstract available
     
     
     
171. KASTURI S, Szymonifka J, Burket JC, Berman JR, et al
     Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Feb 1. pii: jrheum.170590. doi: 10.3899/jrheum.170590.
     PubMed     Abstract available
     
     
     
172. CHEN H, Peng Q, Yang H, Yin L, et al
     Increased Levels of Soluble Programmed Death Ligand 1 Associate with Malignancy in Patients with Dermatomyositis.
     J Rheumatol. 2018 Feb 1. pii: jrheum.170544. doi: 10.3899/jrheum.170544.
     PubMed     Abstract available
     
     
     
173. ALEXANDERSON H, Regardt M, Ottosson C, Alemo Munters L, et al
     Muscle Strength and Muscle Endurance During the First Year of Treatment of Polymyositis and Dermatomyositis: A Prospective Study.
     J Rheumatol. 2018 Feb 1. pii: jrheum.161183. doi: 10.3899/jrheum.161183.
     PubMed     Abstract available
     
     
     
174. LUCAS S, Chang WL, Merien F
     Prevalence and Clinical Significance of Anti-DFS70 in Antinuclear Antibody (ANA)-positive Patients Undergoing Routine ANA Testing in a New Zealand Public Hospital.
     J Rheumatol. 2018;45:289-291.
     PubMed    
     
     
     
175. CHEN YH, Lu CC, Chen HC
     Candida albicans Pyomyositis in a Patient with Systemic Lupus Erythematosus.
     J Rheumatol. 2018;45:286-287.
     PubMed    
     
     
     January 2018
176. BERNATSKY S, Ramsey-Goldman R, Petri M, Urowitz MB, et al
     Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus.
     J Rheumatol. 2018 Jan 15. pii: jrheum.170652. doi: 10.3899/jrheum.170652.
     PubMed     Abstract available
     
     
     December 2017
177. YEUNG Y, Barra LJ
     Cardiovascular Risk Prevention in a Canadian Population of Patients with Giant Cell Arteritis.
     J Rheumatol. 2017;44:1942-1943.
     PubMed    
     
     
     
178. NAVRATIL M, Ivkovic Jurekovic I
     Chloroquine Toxicity Misdiagnosed as Fabry Disease Associated with Systemic Lupus Erythematosus and Hashimoto Thyroiditis.
     J Rheumatol. 2017;44:1940.
     PubMed    
     
     
     
179. BLOCKMANS D
     Fluorodeoxyglucose Positron Emission Tomography for Giant Cell Arteritis.
     J Rheumatol. 2017;44:1763-1764.
     PubMed    
     
     
     November 2017
180. PAKCHOTANON R, Gladman DD, Su J, Urowitz MB, et al
     More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.
     J Rheumatol. 2017 Nov 15. pii: jrheum.170645. doi: 10.3899/jrheum.170645.
     PubMed     Abstract available
     
     
     
181. RICHTER JG, Muth T, Li J, Brinks R, et al
     Elevated Psychosocial Stress at Work in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis.
     J Rheumatol. 2017 Nov 15. pii: jrheum.170233. doi: 10.3899/jrheum.170233.
     PubMed     Abstract available
     
     
     
182. CHEN HL, Shen LJ, Hsu PN, Shen CY, et al
     Cumulative Burden of Glucocorticoid-related Adverse Events in Patients with Systemic Lupus Erythematosus: Findings from a 12-year Longitudinal Study.
     J Rheumatol. 2017 Nov 15. pii: jrheum.160214. doi: 10.3899/jrheum.160214.
     PubMed     Abstract available
     
     
     
183. TSELIOS K, Gladman DD, Su J, Ace O, et al
     Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study.
     J Rheumatol. 2017 Nov 1. pii: jrheum.161121. doi: 10.3899/jrheum.161121.
     PubMed     Abstract available
     
     
     October 2017
184. VITIELLO G, Cammelli D
     Large-vessel Involvement and Varicella Zoster Virus Vasculopathy in Giant Cell Arteritis-related Stroke: Something to Keep an Eye On.
     J Rheumatol. 2017;44:1566.
     PubMed    
     
     
     
185. CHEN Y, Liu J
     What is the Definition of the Anticytoplasmic Autoantibody?
     J Rheumatol. 2017;44:1564.
     PubMed    
     
     
     September 2017
186. ROSSIDES M, Simard JF, Svenungsson E, von Euler M, et al
     Mortality and Functionality after Stroke in Patients with Systemic Lupus Erythematosus.
     J Rheumatol. 2017 Sep 15. pii: jrheum.170241. doi: 10.3899/jrheum.170241.
     PubMed     Abstract available
     
     
     
187. CLIFFORD AH, Murphy EM, Burrell SC, Bligh MP, et al
     Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids.
     J Rheumatol. 2017 Sep 15. pii: jrheum.170138. doi: 10.3899/jrheum.170138.
     PubMed     Abstract available
     
     
     
188. BONEPARTH A, Radhakrishna SM, Greenbaum LA, Yen E, et al
     Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists.
     J Rheumatol. 2017 Sep 15. pii: jrheum.170502. doi: 10.3899/jrheum.170502.
     PubMed     Abstract available
     
     
     
189. 
     Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.
     J Rheumatol. 2017;44:1417.
     PubMed    
     
     
     
190. KUMTHEKAR A, Danve A, Deodhar A
     Use of Belimumab throughout 2 Consecutive Pregnancies in a Patient with Systemic Lupus Erythematosus.
     J Rheumatol. 2017;44:1416-1417.
     PubMed    
     
     
     
191. NANTES SG, Su J, Dhaliwal A, Colosimo K, et al
     Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.
     J Rheumatol. 2017 Sep 1. pii: jrheum.161125. doi: 10.3899/jrheum.161125.
     PubMed     Abstract available
     
     
     
192. ZOHOURY N, Bertolaccini ML, Rodriguez-Garcia JL, Shums Z, et al
     Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of "Non-criteria" Antiphospholipid Antibodies.
     J Rheumatol. 2017 Sep 1. pii: jrheum.170044. doi: 10.3899/jrheum.170044.
     PubMed     Abstract available
     
     
     August 2017
193. BERNATSKY S, Clarke AE, Niaki OZ, Labrecque J, et al
     Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
     J Rheumatol. 2017 Aug 1. pii: jrheum.170179. doi: 10.3899/jrheum.170179.
     PubMed     Abstract available
     
     
     July 2017
194. CHEN Z, Wang Y, Kuwana M, Xu X, et al
     HLA-DRB1 Alleles as Genetic Risk Factors for the Development of Anti-MDA5 Antibodies in Patients with Dermatomyositis.
     J Rheumatol. 2017 Jul 15. pii: jrheum.170165. doi: 10.3899/jrheum.170165.
     PubMed     Abstract available
     
     
     
195. HOZUMI H, Fujisawa T, Enomoto N, Nakashima R, et al
     Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
     J Rheumatol. 2017 Jul 15. pii: jrheum.170373. doi: 10.3899/jrheum.170373.
     PubMed     Abstract available
     
     
     
196. NAGASHIMA T, Iwamoto M, Minota S
     Gottron Sign with Ulceration Is Not a Poor Prognostic Factor in Patients with Dermatomyositis and Interstitial Lung Disease.
     J Rheumatol. 2017;44:1099-1100.
     PubMed    
     
     
     
197. YAP DYH, Tang C, Ma MKM, Mok MMY, et al
     Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years.
     J Rheumatol. 2017 Jul 1. pii: jrheum.170226. doi: 10.3899/jrheum.170226.
     PubMed     Abstract available
     
     
     June 2017
198. BRUNNER HI, Bennett MR, Gulati G, Abulaban K, et al
     Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults.
     J Rheumatol. 2017 Jun 15. pii: jrheum.161128. doi: 10.3899/jrheum.161128.
     PubMed     Abstract available
     
     
     
199. GU K, Gladman DD, Su J, Urowitz MB, et al
     Hospitalizations in Patients with Systemic Lupus Erythematosus in an Academic Health Science Center.
     J Rheumatol. 2017 Jun 15. pii: jrheum.170072. doi: 10.3899/jrheum.170072.
     PubMed     Abstract available
     
     
     
200. KURTZMAN DJB, Weinblatt M, Vleugels RA
     Antimelanoma Differentiation-associated Gene 5 Dermatomyositis.
     J Rheumatol. 2017;44:850-851.
     PubMed    
     
     
     
201. TARABORELLI M, Reggia R, Dall'Ara F, Fredi M, et al
     Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study.
     J Rheumatol. 2017 Jun 1. pii: jrheum.161364. doi: 10.3899/jrheum.161364.
     PubMed     Abstract available
     
     
     
202. HEMKE R, Tzaribachev N, Nusman CM, van Rossum MAJ, et al
     Magnetic Resonance Imaging (MRI) of the Knee as an Outcome Measure in Juvenile Idiopathic Arthritis: An OMERACT Reliability Study on MRI Scales.
     J Rheumatol. 2017 Jun 1. pii: jrheum.160821. doi: 10.3899/jrheum.160821.
     PubMed     Abstract available
     
     
     May 2017
203. QUARTUCCIO L, Baldini C, Priori R, Bartoloni E, et al
     Cryoglobulinemia in Sjogren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue.
     J Rheumatol. 2017 May 15. pii: jrheum.161465. doi: 10.3899/jrheum.161465.
     PubMed     Abstract available
     
     
     
204. FASANO S, Pierro L, Pantano I, Iudici M, et al
     Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
     J Rheumatol. 2017 May 15. pii: jrheum.161351. doi: 10.3899/jrheum.161351.
     PubMed     Abstract available
     
     
     
205. NAKABO S, Yoshifuji H, Hashimoto M, Imura Y, et al
     Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases.
     J Rheumatol. 2017 May 15. pii: jrheum.161432. doi: 10.3899/jrheum.161432.
     PubMed     Abstract available
     
     
     
206. SHI J, Li S, Yang H, Zhang Y, et al
     Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
     J Rheumatol. 2017 May 1. pii: jrheum.161480. doi: 10.3899/jrheum.161480.
     PubMed     Abstract available
     
     
     
207. LE PENDU C, Meignin V, Gonzalez-Chiappe S, Hij A, et al
     Poor Predictive Value of Isolated Adventitial and Periadventitial Infiltrates in Temporal Artery Biopsies for Diagnosis of Giant Cell Arteritis.
     J Rheumatol. 2017 May 1. pii: jrheum.170061. doi: 10.3899/jrheum.170061.
     PubMed     Abstract available
     
     
     
208. KOSTER MJ, Achenbach SJ, Crowson CS, Maradit-Kremers H, et al
     Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study.
     J Rheumatol. 2017 May 1. pii: jrheum.161516. doi: 10.3899/jrheum.161516.
     PubMed     Abstract available
     
     
     
209. MURO Y, Iwata N, Tanaka Y, Kodera M, et al
     Anti-dense Fine Speckled 70 Autoantibodies in Japanese Children with Dermatomyositis, Localized Scleroderma, and Idiopathic Arthritis with Iridocyclitis.
     J Rheumatol. 2017;44:711-712.
     PubMed    
     
     
     
210. GENEST G, Laskin CA
     Safety and Efficacy of in Vitro Fertilization in Women with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
     J Rheumatol. 2017;44:547-549.
     PubMed    
     
     
     April 2017
211. KASTURI S, Szymonifka J, Burket JC, Berman JR, et al
     Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.
     J Rheumatol. 2017 Apr 15. pii: jrheum.161202. doi: 10.3899/jrheum.161202.
     PubMed     Abstract available
     
     
     
212. SIMONINI G, Bracaglia C, Cattalini M, Taddio A, et al
     Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
     J Rheumatol. 2017 Apr 1. pii: jrheum.161336. doi: 10.3899/jrheum.161336.
     PubMed     Abstract available
     
     
     
213. BERNTSEN KS, Tollisen A, Schwartz T, Kirkhus E, et al
     Submaximal Exercise Capacity in Juvenile Dermatomyositis after Longterm Disease: The Contribution of Muscle, Lung, and Heart Involvement.
     J Rheumatol. 2017 Apr 1. pii: jrheum.160997. doi: 10.3899/jrheum.160997.
     PubMed     Abstract available
     
     
     
214. GUERRA F, Gelardi C, Capucci A, Gabrielli A, et al
     Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study.
     J Rheumatol. 2017 Apr 1. pii: jrheum.161311. doi: 10.3899/jrheum.161311.
     PubMed     Abstract available
     
     
     
215. YANG N, Bhattacharyya S, Weinblatt M
     Refractory Syndrome of Inappropriate Secretion of Antidiuretic Hormone in Systemic Lupus Erythematosus-associated Hypophysitis.
     J Rheumatol. 2017;44:541-542.
     PubMed    
     
     
     
216. NIHTYANOVA SI, Denton CP
     Scleroderma Lung Involvement, Autoantibodies, and Outcome Prediction: The Confounding Effect of Time.
     J Rheumatol. 2017;44:404-406.
     PubMed    
     
     
     March 2017
217. ZISMAN D, Gladman DD, Stoll ML, Strand V, et al
     The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.
     J Rheumatol. 2017;44:342-351.
     PubMed     Abstract available
     
     
     
218. HORTON DB, Onel KB, Beukelman T, Ringold S, et al
     Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
     J Rheumatol. 2017;44:352-360.
     PubMed     Abstract available
     
     
     
219. WARD TM, Beebe DW, Chen ML, Landis CA, et al
     Sleep Disturbances and Neurobehavioral Performance in Juvenile Idiopathic Arthritis.
     J Rheumatol. 2017;44:361-367.
     PubMed     Abstract available
     
     
     
220. VAN DAALEN EE, Rahmattulla C, Wolterbeek R, Bruijn JA, et al
     Incidence of Malignancy Prior to Antineutrophil Cytoplasmic Antibody-associated Vasculitis Compared to the General Population.
     J Rheumatol. 2017;44:314-318.
     PubMed     Abstract available
     
     
     
221. AESCHLIMANN FA, Angst F, Hofer KD, Cannizzaro Schneider E, et al
     Prevalence of Anti-infliximab Antibodies and Their Associated Co-factors in Children with Refractory Arthritis and/or Uveitis: A Retrospective Longitudinal Cohort Study.
     J Rheumatol. 2017;44:334-341.
     PubMed     Abstract available
     
     
     
222. STOUSTRUP P, Twilt M, Spiegel L, Kristensen KD, et al
     Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research Studies.
     J Rheumatol. 2017;44:326-333.
     PubMed     Abstract available
     
     
     February 2017
223. GUZMAN J, Henrey A, Loughin T, Berard RA, et al
     Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort.
     J Rheumatol. 2017;44:230-240.
     PubMed     Abstract available
     
     
     
224. FURUTA S, Chaudhry AN, Arimura Y, Dobashi H, et al
     Comparison of the Phenotype and Outcome of Granulomatosis with Polyangiitis Between UK and Japanese Cohorts.
     J Rheumatol. 2017;44:216-222.
     PubMed     Abstract available
     
     
     January 2017
225. THOMAS G, Cohen Aubart F, Chiche L, Haroche J, et al
     Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients.
     J Rheumatol. 2017;44:24-32.
     PubMed     Abstract available
     
     
     June 2016
226. NUSMAN CM, Rosendahl K, Maas M
     MRI Protocol for the Assessment of Juvenile Idiopathic Arthritis of the Wrist: Recommendations from the OMERACT MRI in JIA Working Group and Health-e-Child.
     J Rheumatol. 2016;43:1257-8.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: